CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine

Irving L Weissman; Fiona M Watt

doi:10.1016/j.stem.2016.05.011

CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine

Cell Stem Cell. 2016 Jul 7;19(1):19-22. doi: 10.1016/j.stem.2016.05.011.

Authors

Irving L Weissman¹, Fiona M Watt²

Affiliations

¹ Institute for Stem Cell Biology and Regenerative Medicine and Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, 265 Campus Drive West, Room G3167, Stanford, CA 94305-5461, USA. Electronic address: irv@stanford.edu.
² King's College London Centre for Stem Cells and Regenerative Medicine, Floor 28, Tower Wing, Guy's Hospital Campus, Great Maze Pond, London SE1 9RT, UK. Electronic address: fiona.watt@kcl.ac.uk.

PMID: 27392224
DOI: 10.1016/j.stem.2016.05.011

Abstract

The California Institute for Regenerative Medicine (CIRM) and the UK Regenerative Medicine Platform (UKRMP) have similar objectives, but their histories, funding mechanisms, and governance could hardly be more different. Here, we compare the two programs and explore their impact in translating stem cell research into clinical applications.

MeSH terms

California
Cooperative Behavior
Investments / economics*
Regenerative Medicine / economics*
Stem Cell Research / economics
Translational Research, Biomedical / economics
United Kingdom

Abstract

MeSH terms

Grants and funding